Glanzmann C, Sialer G, Horst W
Strahlentherapie. 1978 Sep;154(9):627-31.
We investigated the function of the parotid and submandibular glands in normals and in patients with radiotherapy in the head neck region by scintigraphic methods. The above given doses relate to an application scheme with 200 rd 5 times per week. There is a relatively severe loss of function with small doses from 1000 to 2000 rd. After doses till 3000 rd, there is complete recovery of the gland function in about three months. After 4500 rd, there is in about 80% of the patients a complete recovery after about one year. After irradiation with 5000 or more rd, there is nearly in no person a recovery of the gland function. We did not find a compensatory increase in the function of a spared gland with compensation of irreversibly atrophic glands.
我们通过闪烁扫描法研究了正常人和头颈部放疗患者腮腺和颌下腺的功能。上述剂量与每周5次、每次200拉德的应用方案相关。剂量在1000至2000拉德之间时,功能会有相对严重的丧失。剂量达3000拉德后,腺体功能约在三个月内完全恢复。剂量为4500拉德后,约80%的患者在约一年后完全恢复。剂量为5000拉德及以上时,几乎无人的腺体功能能够恢复。我们未发现未受照射腺体功能的代偿性增加以补偿不可逆萎缩的腺体。